Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: Is it significant?

被引:47
作者
Selvaggi, SM [1 ]
机构
[1] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI USA
关键词
cervical cytology; Thin Prep (R) Pap Tests (TM); 2001 Bethesda nomenclature system; atypical squamous cells; cannot exclude a high-grade squamous intraepithelial lesion;
D O I
10.1002/dc.10303
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) is a new diagnostic category it? the 2001 Bethesda nomenclature system for cervical cytology. The purpose of this 7-mo retrospective study (March 1, 2002-Septemher 30, 2002) was to evaluate the significance of ASC-H on cervical Thin Prep(R) Pap Tests(TM). During this period, 25 (0.27%) of 9,214 Pap Tests were diagnosed as ASC-H, 22 of which resulted in either follow-up cervical biopsies and/or cervical cones, and which formed the basis of this study. Tissue specimens (22 cases) were negative in 5 cases (23%) and positive in 17 cases (77%). Of the positive specimens, there were 2 (12%) low-grade squamous intraepithelial lesions (LSIL) and 15 (88%) high-grade squamous intraepithelial lesions (HSIL). Of the 22 cases, ASC-H diagnoses included immature/atypical squamous inetaplasia vs. a squamous intraepithelial lesion (SIL) in 19 (86%) cases, and tight clusters of small cells with a high nuclear to cytoplasmic ratio in 3 (14%) cases. The results of this study indicate that the reporting of ASC-H on cervical samples does lead to the detection of HSILs in a significant number of cases (68% in this study). Therefore, further evaluation of the patient is warranted. Diagn. Cytopathol. 2003;29:38-41. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:38 / 41
页数:4
相关论文
共 21 条
[1]  
ALLI PM, 1999, ACTA CYTOL, V43, P915
[2]  
BUSCHMAN BO, 1995, ACTA CYTOL, V39, P970
[3]  
Crum CP, 1999, AM J CLIN PATHOL, V112, P384
[4]  
Dressel, 1997, PATHOL CASE REV, V2, P53
[5]  
Kline MJ, 1996, DIAGN CYTOPATHOL, V14, P380, DOI 10.1002/(SICI)1097-0339(199605)14:4<380::AID-DC18>3.0.CO
[6]  
2-G
[7]  
Kurman RJ, 1994, BETHESDA SYSTEM REPO
[8]  
LOURO AP, 2002, ACTA CYTOL, V46, P937
[9]  
MAHOOD LK, 2002, ACTA CYTOL, V46, P938
[10]  
MELAMED MR, 1976, ACTA CYTOL, V20, P108